HerWellReport Independent Women’s Health Research

Menopause

One A Day Women’s Menopause Formula: An Honest Ingredient Review

A woman in her fifties browses a drugstore shelf, in warm terracotta tones

This site is reader-supported. If you buy through a link on this page we may earn a commission, at no extra cost to you. See our affiliate disclosure. Nothing here is medical advice — see our medical disclaimer.

One A Day Women’s Menopause Formula is one of the easiest menopause supplements to find — it sits on the shelf at Walmart, CVS, Target and most grocery pharmacies for about the price of a multivitamin, because that is mostly what it is. Bayer markets it with one specific line: “specially formulated with soy isoflavones to help reduce hot flashes.” We looked at what’s actually in the tablet, what dose it delivers, and whether that claim holds up against the current evidence.

What it actually is

Strip away the “Menopause Formula” name and this is a standard One A Day multivitamin — 20-plus vitamins and minerals at levels aimed at a midlife woman (extra calcium and vitamin D for bone health, B-vitamins, zinc, biotin) — with one addition: 60 mg of soybean isoflavones per tablet. One tablet a day, with food. A 50-count bottle runs about $21.60, and it’s sold at essentially every major US retailer, so stock and price are not in question the way they are for some smaller brands. (Short on time? Skip to our alternative.)

The soy isoflavones are the only ingredient in the formula that is specifically positioned as a menopause treatment rather than general nutrition. Everything else — the vitamin D, the B12, the zinc — is the same rationale you’d find on any women’s-over-45 multivitamin, menopausal or not.

The label, in full

Bayer’s own product page shows the Supplement Facts panel as an image rather than searchable text, and doesn’t spell out the isoflavone dose in the marketing copy. The full panel is published, though, on retailer pages that carry the product (we cross-checked Vitacost’s listing against the label image on Bayer’s site):

NutrientAmount% Daily Value
Vitamin A750 mcg83%
Vitamin C60 mg67%
Vitamin D20 mcg (800 IU)100%
Vitamin E14.8 mg99%
Vitamin B68 mg471%
Folate665 mcg DFE166%
Vitamin B1212 mcg500%
Biotin300 mcg1000%
Calcium300 mg23%
Magnesium50 mg12%
Zinc15 mg136%
Chromium120 mcg343%
Soybean isoflavones60 mgNot established

(Several B-vitamins and trace minerals are omitted from this table for length — the full panel runs to about 20 nutrients in total.) Several of the vitamins sit at 300–1000% of the Daily Value, which is normal for a fortified multivitamin and not a safety concern at these doses, but it does mean this product duplicates whatever a woman is already getting from a separate multivitamin if she takes both.

Does 60 mg of soy isoflavones actually help hot flashes?

This is the specific, checkable claim on the box, so it’s worth checking against the most current guideline rather than an old headline. The North American Menopause Society (NAMS) published an updated nonhormone therapy position statement in 2023, grading the evidence for every non-prescription option women commonly try for hot flashes. Soy products were placed in the “not recommended or insufficient evidence” category, alongside most other herbal and dietary supplements — the statement’s evidence-backed nonhormone recommendations centre instead on specific prescription options (certain SSRIs/SNRIs, gabapentin, fezolinetant) and cognitive behavioural therapy.

That doesn’t mean soy isoflavones do nothing for every woman — trial results in this area have genuinely been inconsistent, with some smaller or shorter studies showing a modest reduction in hot flash frequency and others showing no real difference from placebo, which is exactly the pattern that produces a “not recommended” grade rather than a “works” or “doesn’t work” one. What it does mean is that a supplement box claim as specific as “specially formulated… to help reduce hot flashes” is stating something more definite than the current clinical guidance actually supports.

It’s also worth noting the 60 mg dose sits inside a general multivitamin rather than a standalone product, so isoflavones aren’t the tablet’s only job — which makes it harder to isolate any effect even if you wanted to track one.

Soy isoflavones and interactions worth knowing about

Soy isoflavones aren’t risk-free just because they’re marketed as gentle. Two interactions are relevant to the exact age group this product targets:

  • Thyroid medication. Soy can reduce or delay the absorption of levothyroxine. This isn’t a drug-interaction in the classic sense — no direct chemical clash is documented — but soy taken close to a levothyroxine dose can lower how much of the medication actually gets absorbed. The practical fix is timing: keep several hours between the two rather than taking them together, and stay consistent about when you take your thyroid medication relative to food.
  • Tamoxifen and hormone-receptor-positive breast cancer. Memorial Sloan Kettering’s integrative medicine reference flags that genistein, the main isoflavone in soy, may antagonise tamoxifen’s effect based on animal research — though it notes clinical relevance in humans “has yet to be determined.” Separately, genistein has been shown to stimulate growth in some estrogen-dependent tumour models and to raise aromatase activity, which is the enzyme aromatase inhibitors are designed to block. Anyone on tamoxifen, an aromatase inhibitor, or being monitored for a hormone-sensitive cancer should talk to their oncology team before adding a soy isoflavone supplement — including one packaged as an ordinary multivitamin.

Neither of these makes the product dangerous for most women. They’re the kind of specific, checkable caution a supplement box has no space for, and exactly the kind of thing worth a two-minute conversation with a pharmacist before starting anything daily.

Price and where it’s sold

At roughly $21.60 for 50 tablets (about 43 cents a day), it’s priced like a mainstream multivitamin, not like a specialty menopause supplement — considerably cheaper per day than most of the DTC menopause brands we’ve reviewed, several of which run $1–2 a day for a proprietary blend with no published doses at all. It’s carried by Walmart, CVS, Target, Publix, Vitacost, iHerb and Amazon, so availability and price shopping are not a problem here the way they can be with smaller online-only brands.

The search results tell their own story

Search “One A Day Women’s Menopause Formula review” and the page is retailer review pages (Walmart, Amazon), a drug-interaction database, an influencer review aggregator, and a handful of thin affiliate sites — no major medical publisher has written an independent assessment of this specific product. That’s common in this category: a mainstream drugstore brand with real distribution but no scrutiny of whether its one menopause-specific ingredient is dosed for effect.

Bottom line

One A Day Women’s Menopause Formula is, functionally, an honest-value multivitamin for midlife women with a modest, disclosed dose of soy isoflavones added on. The dose (60 mg) is published, which is more than most of the menopause supplements we cover can say, and the price is low. Where it oversells is the specific hot-flash claim on the box: the current NAMS guidance places soy products in the “not recommended or insufficient evidence” category, so the marketing states more certainty than the evidence currently supports. If you’re taking thyroid medication or you’re on tamoxifen or an aromatase inhibitor, that soy addition is worth a specific conversation with your pharmacist or oncology team before you start it — not because it’s necessarily a problem, but because it’s exactly the kind of interaction a drugstore shelf label has no room to mention.

Looking for a menopause supplement with fully disclosed doses on every ingredient, not just one? We’ve written a full, honest MenoRescue review covering what’s in it, what the evidence says, and its guarantee terms.

Check current pricing on the official site →

Affiliate link — we may earn a commission at no extra cost to you. We have not used or tested this product.

FAQ

Does One A Day Women’s Menopause Formula actually reduce hot flashes?

It contains 60 mg of soy isoflavones, which is the ingredient tied to that claim, but the 2023 NAMS position statement lists soy products under “not recommended or insufficient evidence” for hot flashes. Trial results on soy isoflavones have been mixed rather than consistently positive.

How much soy isoflavones does it contain?

60 mg per tablet, one tablet daily. This is published on retailer label images though not spelled out in Bayer’s own marketing copy.

Can I take it if I’m on thyroid medication?

Soy can reduce how much levothyroxine your body absorbs if taken close together. Spacing the two by several hours is the usual practical fix — ask your pharmacist about your specific timing.

Is it safe to take with tamoxifen or an aromatase inhibitor?

Talk to your oncology team first. Animal research suggests the soy compound genistein may interfere with tamoxifen’s effect, and genistein has been shown to stimulate some estrogen-dependent tumour models in lab studies, though human clinical relevance isn’t settled.

We have not tested this product ourselves — this review is based on the published label, the manufacturer’s own marketing claims, and current published evidence. We publish no star ratings and no testimonials, on this page or anywhere on the site, by policy.

Sources

  1. One A Day — Women’s Menopause Formula, official product page
  2. Vitacost — One-A-Day Women’s Menopause Formula, full Supplement Facts panel and price
  3. The 2023 nonhormone therapy position statement of The North American Menopause Society — PubMed
  4. U.S. Pharmacist — summary of the 2023 NAMS nonhormone therapy position statement
  5. The ObG Project — NAMS 2023 nonhormone therapy position statement summary
  6. Drugs.com — levothyroxine and soy interaction, absorption timing
  7. Memorial Sloan Kettering Cancer Center — Soy Isoflavones, integrative medicine reference (tamoxifen, hormone-sensitive cancer)

More from HerWellReport